$0.6589
0.00110.17%
Last update: Oct 13, 4:00 PM
Standard BioTools Inc
LABNASDAQ
Standard BioTools (LAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Standard BioTools (LAB) last issued guidance on May 5, 2026 for fiscal year 2026. The company guided revenue in the range of $80M - $85M for the period.
Compared to prior guidance, Standard BioTools maintained its revenue forecast from a prior range of $80M - $85M.
Standard BioTools has issued 21 guidance updates between January 9, 2023 and May 5, 2026. During this period, the company raised its outlook 5 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.02 | $-0.04 | $-0.04 |
| Actual | $-0.07 | $-0.04 | $0.05 | $-0.09 |
| Surprise | -133.3% | -100.0% | +225.0% | -125.0% |
| Revenue | ||||
| Estimate | $20.9M | $17.8M | $18.5M | $18.0M |
| Actual | $20.1M | $21.1M | $23.8M | $19.6M |
| Surprise | -3.90% | +19.1% | +28.6% | +8.62% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.02 | $-0.02 |
| Revenue | ||
| Consensus | $18.8M | $21.0M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.07 | $-0.03 | -133.3 % |
| Q1 | May 5, 2026 | $-0.04 | $-0.02 | -100.0 % |
| Q4 | Feb 24, 2026 | $0.05 | $-0.04 | 225.0 % |
| Q3 | Nov 4, 2025 | $-0.09 | $-0.04 | -125.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $20.10M | $20.92M | -3.90 % |
| Q1 | May 5, 2026 | $21.15M | $17.75M | 19.1 % |
| Q4 | Feb 24, 2026 | $23.80M | $18.50M | 28.6 % |
| Q3 | Nov 4, 2025 | $19.55M | $18.00M | 8.62 % |
